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522Objectives: Cardiovascular allografts in the young have limited durability because of early graft calcification.
The objective of this study was to examine the hypothesis that growth-associated hyperphosphatemia in youth
accelerates aortic allograft calcification by osteogenic transformation of graft medial smooth muscle cells
(SMCs).
Methods: The descending aortas of donor rats were subcutaneously transplanted into recipients. Syngeneic
(Lewis-to-Lewis) transplantations between 3-week-old ‘‘young’’ (Y) rats and between 10-week-old ‘‘adult’’
(A) rats were combined with standard (ST, 0.9% phosphate) and low-phosphate (LP, 0.2%) diets, resulting
in Y-ST, Y-LP, and A-ST groups. Allotransplantations (Brown-Norway–to–Lewis) involving these ages and
diets were also made. The grafts and sera were retrieved from recipients after 14 days. Cultured rat aortic
SMCs were used to analyze the effects of tumor necrosis factor-alpha (TNF-a) and phosphate on SMC
calcification.
Results: In vivo, serum phosphate levels were higher in Y-ST (11.5 mg/dL) than those in Y-LP (8.9 mg/dL) and
A-ST (8.5 mg/dL). Graft medial calcification appeared severe only in Y-ST. Allotransplants did not affect these
outcomes. Graft medial cells showed phenotypic changes (contractile to synthetic) and osteogenic transforma-
tion (a-smooth muscle actin to Runx2 and osteocalcin), together with up-regulated proinflammatory TNF-a and
sodium–phosphate cotransporter, Pit-1, despite ages and diets. In vitro, TNF-a induced phenotypic changes and
osteogenic transformation of SMCs with Pit-1 up-regulation, but SMC calcification occurred only with high
phosphate (4.5 mmol/L).
Conclusions: Growth-associated hyperphosphatemia with inflammatory responses may be essential for ac-
celerating allograft calcification in youth and could be a therapeutic target. (J Thorac Cardiovasc Surg
2013;145:522-30)Allografts have been useful in cardiovascular surgery for
several decades, offering advantages of tissue compatibility,
hemodynamics, and avoidance of long-term anticoagulant
therapies.1 However, accelerated graft degeneration and
calcification in young patients, especially neonates and in-
fants, limit their durability.2-5 Immunoreactions may have
roles in allograft degeneration,5 but the etiology of acceler-
ated allograft calcification in young patients is still
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The Journal of Thoracic and Cardiovascular SurgVascular calcification has recently been recognized
to arise from active osteogenesis.6 Uremic vasculopathy
is characteristic of accelerated medial calcification
(M€onckeberg sclerosis), particularly when accompanied
with hyperphosphatemia and inflammation.7 In vitro, in-
organic phosphate (Pi) induced vascular smooth muscle
cell (SMC) calcification by transforming SMC pheno-
types from the myogenic lineage, such as a-smooth mus-
cle actin (a-SMA), to the osteogenic lineage, such as
Runx2/Cbfa1 (a transcriptional factor for osteoblastic
differentiation) and osteocalcin (noncollagenous bone
protein), via type 3 sodium–phosphate cotransporters,
Pit-1.8-10 Tumor necrosis factor-alpha (TNF-a), a proin-
flammatory cytokine mainly secreted by macrophages,
orchestrates inflammatory responses in uremic arteriopa-
thy11 and also provokes in vitro vascular SMC calcifica-
tion by osteogenic transformation.12,13
Unlike uremia, in which hyperphosphatemia is induced
mainly by impaired Pi excretion, growth-associated
hyperphosphatemia is characteristic of positive bone
turnover in the young inasmuch as growth hormone pro-
motes Pi reabsorption and inhibits the intact parathyroid
hormone (iPTH) effect of Pi excretion in the kidneyery c February 2013
Abbreviations and Acronyms
a-SMA ¼ a-smooth muscle actin
A-allo-ST ¼ adult allogeneic-transplant with
standard diet
A-ST ¼ adult syngeneic-transplant with
standard diet
BN ¼ Brown-Norway
cAMP/PKA ¼ cyclic adenosine monophosphate/
protein kinase A
CD ¼ cluster of differentiation
HP ¼ high inorganic phosphate
iPTH ¼ intact parathyroid hormone
LP ¼ low inorganic phosphate (diet)
PCR ¼ polymerase chain reaction
Pi ¼ inorganic phosphate
POD ¼ postoperative day
RAOSMC ¼ rat aortic smooth muscle cell
SMC ¼ smooth muscle cell
ST ¼ standard (diet)
TNF-a ¼ tumor necrosis factor-alpha
Y-allo-ST ¼ young allogeneic-transplant with
standard diet
Y-ST ¼ young syngeneic-transplant with
standard diet
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Stubules.14 This leads to a higher prevalence of vascular
calcification in young uremic patients.7 In a rat model,
the involvement of growth-associated hyperphosphatemia
in warfarin-induced arterial calcification was suspected,
although its detailed mechanisms were not elucidated.15
We therefore hypothesize that growth-associated hyper-
phosphatemia accelerates allograft calcification in young
recipients by the osteogenic transformation of graft
SMCs in collaboration with the TNF-a–mediated
inflammatory response against the grafts. To examine
this hypothesis, we used a rat aortic subcutaneous trans-
plant model and a rat aortic SMC (RAOSMC) culture
system.MATERIALS AND METHODS
Animals and Diets
Three-week-old ‘‘young’’ male Lewis rats (RT1AlBl) and Brown-
Norway (BN) rats (RT1AnBn) weighing 50 to 60 g, 10-week-old ‘‘adult’’
male Lewis (270-290 g) and BN (200-220 g) rats were purchased from
Charles River Laboratories Japan (Yokohama, Japan) 1 week before exper-
imentation. A standard (ST) rat diet (0.9% of Pi, 1.1% of calcium) and
a low Pi (LP) diet (0.2% Pi, 1.1% calcium) were obtained from Oriental
Yeast (Tokyo, Japan).16
Rat Aortic Subcutaneous Transplant Model
Rats were anesthetized with intraperitoneal pentobarbital (Nembutal;
Hospira, Inc, Lake Forest, Ill; 35mg/100 g bodyweight). Under sterile con-
ditions, the descending aortas of the donor rats were harvested and kept inThe Journal of Thoracic and Caheparinized saline (4C) as fresh grafts until they were implanted in the
subcutaneous pockets of the recipients’ abdomens, as described else-
where.17 The time from harvest to implantation did not exceed an hour.
Each recipient rat received subcutaneous ampicillin (10 mg/100 g body
weight) once in its back.
Aortic transplantation was performed between the young rats (the
young group) and, separately, between the adult rats (the adult group).
Syngeneic (Lewis-to-Lewis) and allogeneic (BN-to-Lewis) transplanta-
tions were performed in each age group. Young recipients were fed an
ST or an LP diet, whereas adult recipients and all donors received an
ST diet throughout the experimental period, resulting in syngeneic- and
allogeneic-transplant young (Y-ST and Y-allo-ST) and adult (A-ST and
A-allo-ST) groups, all receiving an ST diet, and young groups receiving
an LP diet (Y-LP and Y-allo-LP). The young and adult groups before
transplantation were defined respectively as the Preop-Y and Preop-A
groups. At postoperative day (POD) 7 and POD 14 for the Y-ST group
and at POD 14 for the other groups, the recipients were anesthetized as
described above, and the grafts were retrieved (n ¼ 6 per group). Then,
all recipients were humanely killed by cardiac puncture and the sera
were immediately separated by centrifugation. The retrieved grafts and
sera were promptly analyzed as follows. Anesthetic and surgical protocols
were approved by the Ethics Committee on Animal Research of the Uni-
versity of Tokyo.
Serum Test
The serum calcium, Pi, and iPTH of each rat were measured by the
o-cresolphthalein complexone method18 (Calcium C-test; Wako, Osaka,
Japan), by the phosphate molybdenum blue method19 (Phosphor C-test;
Wako), and with a rat total iPTH enzyme-linked immunosorbent assay
kit (Scantibodies Laboratory, Santee, Calif), respectively. Radioimmuno-
assays of serum vitamin D [1,25-dihydroxycholecalciferol; 1,25(OH)2D]
were performed by SRL, Inc (Tokyo, Japan).
Immunohistochemistry, von Kossa Staining, and
Electron Microscopy of Grafts
A 4-mm thick frozen section of each graft was examined immunohisto-
chemistry,20 using primary antibodies against a-SMA (clone 1A4; Sigma-
Aldrich, St Louis, Mo), cluster of differentiation 68 (CD68) (AbD Serotec,
Oxford, United Kingdom), Runx2 (Sigma-Aldrich), and osteocalcin (Santa
Cruz Biotechnology, Santa Cruz, Calif). The positive controls were rat
spleen (CD68) and fetal spine (Runx2 and osteocalcin), and the negative
control was isotype-matched normal immunoglobulin. Graft calcification
was detected by von Kossa staining. Microstructures were observed by
transmission electron microscopy (H-7000; Hitachi, Tokyo, Japan) per-
formed as described elsewhere.21
Quantification of Calcium and Pi in Grafts
The calcium content of grafts was quantified by atomic absorption spec-
troscopy22 by SRL. The tissue Pi content was measured by the Phosphor
C-test19 (Wako). The amounts of calcium and of Pi in each graft were ex-
pressed as milligrams per dry weight in grams.
Real-Time Polymerase Chain Reaction (PCR) of
Grafts
Total RNAwas extracted from each graft tissue and real-time PCR was
performed20 using the following target gene primer sequences: b-actin,
(forward) 50-ATTGAACACGGCATTGTCACC-30 (reverse) 50-GCAT
GAGGGAGCGCGTAAC-30; a-SMA, (forward) 50-GAGAAGCTGCTC
CAGCTATGT-30 (reverse) 50-GATGATGCCGTGTTCTATCG-30; TNF-a,
(forward) 50-TCCAGAACTCCAGGCGGTGT-30 (reverse) 50-GGCAAA
TCGGCTGACGGTGT-30; Pit-1, (forward) 50-GTCTGGTTCTTCGTA
TGTCCC-30 (reverse) 50-GAACTGAACAAGGTTCCCATTA-30; Runx2,
(forward) 50-ATTCCTCATCCCAGTATGAGAGTAGGT-30 (reverse)rdiovascular Surgery c Volume 145, Number 2 523
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GCAGTAAGGTGGTGAATA-30 (reverse) 50-AACGGTGGTGCCATA
GATG-30. For osteocalcin determination, betaine monohydrate (Sigma-
Aldrich) was added to the PCR solution because of its rich guanine–
cytosine content.23 A duplicate run for each sample was tested and
the average was used. The messenger RNA expression of each graft
was calculated and expressed as a ratio of that of the internal control,
b-actin.
Immunocytochemistry
A cell culture system was prepared as described elsewhere.8,10
RAOSMCs (Cell Applications, San Diego, Calif) cultured in glass-
bottom dishes (Matsunami, Osaka, Japan) were subdivided into a TNF(þ)
group with 50 ng/mL of TNF-a (Sigma-Aldrich) and a TNF() group with-
out it. Mouse osteoblasts (JCRB1178; Health Sciences Foundation, Tokyo,
Japan) were cultured without TNF-a. After 7 days, cells were double-
stained with a-SMA combined with Runx2, osteocalcin, or normal immu-
noglobulin, using primary antibodies against a-SMA (clone 1A4,
Cy3-conjugated, Sigma-Aldrich), Runx2, and osteocalcin (as described
in ‘‘Immunohistochemistry’’). Each dish with cultured cells was blocked
with horse serum and incubated overnight at 4C with the primary anti-
bodies. Then, the secondary antibodies for Runx2 and osteocalcin labeled
with Alexa488 were applied and each dish was observed under a confocal
laser scanning microscope (FV300; Olympus, Tokyo, Japan).
Von Kossa Staining and Electron Microscopy of
RAOSMCs
RAOSMCs subdivided into TNF(þ) and TNF() groups as well as mouse
osteoblasts were combined with high Pi (HP, 4.5 mmol/l) and low Pi (LP,
1.5 mmol/L) media by adding Pi (NaH2PO4/Na2HPO4; 0.1 mmol/L, pH
7.0, Wako). After 14 days, cells were fixed and subjected to von Kossa
staining.8 The same groups of RAOSMCs, after 7 days of culture, were
fixed, gathered, and centrifuged to form a white pellet, which was treated
for transmission electron microscopy.21
Calcium Content in RAOSMCs
Pi at 1.5, 2.5, 3.5, and 4.5 mmol/L was administered on RAOSMCs sub-
divided into TNF(þ) and TNF() groups. After 14 days, the calcium content
of RAOSMCs was determined by the Calcium C-test18 (Wako) and stan-
dardized by their protein content.8Real-time PCR of RAOSMCs
RAOSMCs were divided into 6 groups, to which TNF-a was adminis-
tered in respective concentrations of 0, 0.1, 1, 10, 50, and 100 ng/mL for
7 days. Then, RNAwas extracted with an RNA mini kit (Qiagen, Duessel-
dorf, Germany), and real-time PCR was performed20 for b-actin, a-SMA,
Runx2, osteocalcin, and Pit-1.Statistical Analysis
Measurements were presented as mean  standard error of the mean.
Statistical significance was evaluated by analysis of variance, followed
by comparisons between control and experimental conditions by the Dun-
nett test or the Tukey-Kramer honestly significant difference test among
multiple groups, using JMP version 9 (SAS Institute, Inc, Cary, NC).RESULTS
Effects of Young Age, Alloantigen, and Dietary
Phosphate Restriction on Graft Calcification
In the young syngeneic- and allogeneic-transplant groups
on a standard diet (Y-ST and Y-allo-ST groups), von Kossa524 The Journal of Thoracic and Cardiovascular Surgstaining revealed severe medial calcification, but none in
the preoperative young (Preop-Y) and adult (Preop-A)
groups, and little or none in the young posttransplant groups
on a low phosphate diet (Y-LP and Y-allo-LP) or the adult
groups (A-ST and A-allo-ST), irrespective of the presence
of alloantigen (Figure 1, A). The calcium content of the
grafts was significantly higher in the Y-ST and Y-allo-ST
groups than in the others (Figure 1, B). Similar results
were observed in graft Pi content in the syngeneic-
transplant groups (Figure 1, C). These findings suggest
that young age encourages graft calcification regardless of
the degree of immunoreaction.
Body Weight and Serum Parameters Relevant to
Tissue Calcification
The rats’ body weights in the Y-LP and Y-allo-LP groups
showed growth retardation. The Y-ST group had, as serum
factors relevant to calcium metabolism, higher Pi and lower
iPTH levels than the A-ST group, whereas calcium and
1,25(OH)2D were not significantly different. In the Y-LP
group, Pi and iPTH were significantly lower and calcium
and 1,25(OH)2D higher than in the Y-ST group. Similar dif-
ferences owing to age factors and dietary Pi inhibition were
observed in the allogeneic group, although calcium and
1,25(OH)2D tended to be higher than in the syngeneic group
(Table 1). These results suggest that only the serum Pi level
reflects the severity of graft calcification.
Microstructures of the Graft Medial Cells
To investigate why young age encourages graft calcifica-
tion, we further examined syngeneic grafts of both age
groups. On electron microscopy, the graft medial cells in
both age groups appeared flat preoperatively, with cyto-
plasms rich in actin filaments, typical characteristics of
the contractile phenotype of SMCs (Figure 2, A and B).
The intracellular actin filaments appeared diminished in
size and number, but were still present at POD 7
(Figure 2, C), although further diminished in both age
groups at POD 14 (Figure 2, D and E). Postoperatively,
however, matrix vesicles, characteristic of the synthetic
phenotype of SMCs, appeared in the cytoplasm, and matri-
ces were partially secreted into the extracellular spaces in
both groups. Dense calcium deposition was observed in
the Y-ST group (Figure 2, C and E), whereas the margins
of matrices were only slightly calcified in the A-ST group
(Figure 2, D). In the Y-LP group, as in the Y-ST group, ma-
trix vesicles were present, but without calcified matrices
(Figure 2, F).
Gene Expressions of the Graft Media
Immunohistochemical staining showed that the graft me-
dia preoperatively expressed abundant a-SMA, but no
CD68, Runx2, or osteocalcin in either age group. Postoper-
atively, a-SMA was much less expressed in the grafts,ery c February 2013
FIGURE 1. Analyses of aortic graft calcification. A, Von Kossa staining of the grafts showing calcification in black. Preop-Y and Preop-A, Preoperative
young and adult groups; Y-ST and Y-allo-ST, young syngeneic- and allogeneic-transplant groups at postoperative day (POD) 14 on a standard (ST) diet, re-
spectively; Y-LP and Y-allo-LP, young syngeneic- and allogeneic-transplant groups, respectively, on a low phosphate (LP) diet; A-ST and A-allo-ST, synge-
neic- and allogeneic-transplant adult groups on an ST diet, respectively. BN, Brown-Norway; I, intima; M, media; A, adventitia. Magnification 3200.
Bar ¼ 100 mm. B and C, Calcium and inorganic phosphate (Pi) contents of grafts (n ¼ 6 per group). *P<.05 by Tukey-Kramer honestly significant dif-
ference test; NS, not significant.
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around the graft media. Runx2 and osteocalcin were also
stained along the elastic graft media laminae (Figure 3,
A). In real-time PCR, mRNA expression of a-SMA was
down-regulated, whereas those of TNF-a, Pit-1, Runx2,
and osteocalcin were up-regulated in the postoperative
Y-ST, Y-LP, and A-ST groups. However, there were no
significant differences among the Y-ST, the Y-LP, andTABLE 1. Body weight and serum parameters of rat aortic transplant mo
Body weight (g) Calcium (mg/dL)
Preop-Y 55.0  1.7* 8.7  0.4*
Y-ST 117.7  2.5 10.9  0.2
Y-LP 89.0  2.5* 13.6  0.8*
Y-allo-ST 125.7  1.6 12.7  0.1
Y-allo-LP 99.7  2.9* 16.2  0.4*
Preop-A 281.3  3.3*,y 10.0  0.3
A-ST 304.7  1.6* 11.0  0.2
A-allo-ST 322.7  2.9*,y 15.5  1.2*,y
The data represent mean  standard error (n ¼ 6 per group). Pi, Inorganic phosphat
Preop-Y, young group before transplantation; Y-ST, young syngeneic-transplant with st
Y-allo-ST, young allogeneic-transplant with standard diet; Y-allo-LP, young allogeneic-tr
tation; A-ST, adult syngeneic-transplant with standard diet; A-allo-ST, adult allogeneic-tra
the adult group by the Dunnett method.
The Journal of Thoracic and Cathe A-ST groups, except that Runx2 was significantly
higher in the A-ST than in the Y-ST group (Figure 3, B-F).
Coeffects of TNF-a and Phosphate on Rat Aortic
SMCs
The role of SMCs in graft calcification was examined
using the RAOSMC culture. First, we investigated the ef-
fects of TNF-a on RAOSMCs. Immunocytochemistrydels
Pi (mg/dL) 1,25(OH)2D (pg/mL) iPTH (pg/mL)
10.2  0.6 274.2  18.2 201.1  25.8
11.5  0.6 346.5  10.6 264.3  15.5
8.9  0.4* 846.2  83.8* 69.4  10.6*
10.5  0.4 465.3  17.2 Not examined
8.9  0.7* 971.0  20.1* Not examined
8.1  0.3* 237.0  30.7 385.4  36.0y
8.5  0.3* 251.0  24.7 721.6  84.2*
8.5  0.3* 389.7  20.1y Not examined
e; 1,25(OH)2D, 1,25-dihydroxycholecalciferol; iPTH, intact parathyroid hormone;
andard diet; Y-LP, young syngeneic-transplant with low inorganic phosphate diet;
ansplant with low inorganic phosphate diet; Preop-A, adult group before transplan-
nsplant with standard diet. *P<.05 vs Y-ST in both age groups. yP<.05 vs A-ST in
rdiovascular Surgery c Volume 145, Number 2 525
FIGURE 2. Microstructures of the grafts (electron microscopy). The photographs of the grafts were obtained preoperatively (A and B) and at POD 7 from
the Y-ST group (C) and at POD 14 from the A-ST, Y-ST, and Y-LP groups (D to F). Arrows indicate actin filaments. Asterisks indicate calcium deposition.
POD, Postoperative day; Y-ST, young syngeneic-transplant with standard diet; A-ST, adult syngeneic-transplant with standard diet; Y-LP, young syngeneic-
transplant with low inorganic phosphate diet; N, nucleus; Af, actin filaments;Mt,mitochondria;MVs,matrix vesicles;Mx,matrix. Magnification320,000.
Bar ¼ 1 mm. For abbreviations see Figure 1.
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from myogenic (a-SMA) to osteogenic (Runx2 and osteo-
calcin) on TNF-a treatment (50 ng/mL) (Figure 4, A). Us-
ing real-time PCR, the mRNA expression of a-SMA in
RAOSMCs was significantly down-regulated, whereas
those of Runx2, osteocalcin, and Pit-1 were up-regulated
by TNF-a, both dose-dependently (Figure 4, B and C).
Second, we evaluated the coeffects of TNF-a and Pi on
RAOSMCs. RAOSMCs were severely calcified on costi-
mulation with TNF-a (50 ng/mL) and high Pi (4.5
mmol/L), but not with either alone (Figure 4, D). In
RAOSMCs, calcium content increased significantly in pro-
portion to the Pi concentration only in the TNF-a-treated
media (50 ng/mL) (Figure 4, E). Electron microscopy
revealed diminished numbers of actin filaments in
RAOSMCs with TNF-a, but newly developed rough526 The Journal of Thoracic and Cardiovascular Surgendoplasmic reticula and matrix vesicles, despite the Pi
concentration in the TNF-a-treated media. Calcium depo-
sition in the matrix vesicles appeared only in RAOSMCs
treated with high Pi media (Figure 4, F).
DISCUSSION
In this study, our transplant models demonstrated that
aortic allograft calcification, accelerated in young, but not
adult, rats, was suppressed by lowering serum Pi to the adult
level, suggesting that growth-associated hyperphosphate-
mia promotes allograft calcification. Not only serum Pi
but also calcium, 1,25(OH)2D, and iPTH have been re-
ported to promote vascular calcification.7 In the present
study, however, the levels of calcium and 1,25(OH)2D
were similar in the 2 age groups, and both rose on Pi sup-
pression. Thus, these factors cannot be the primary causesery c February 2013
FIGURE 3. Gene expressions in the grafts. A, Von Kossa staining and immunohistochemical stainings of smooth muscle cell-alpha (a-SMA), cluster of
differentiation (CD) 68, Runx2, and osteocalcin in the same specimens of syngeneic-transplant group grafts. Protein expression appears red on immuno-
staining. Positive control: Rat spleen for CD68; rat fetal spine for Runx2 and osteocalcin. Small window: Staining of normal immunoglobulin. Magnification
3200. Bar¼ 100 mm. B-F, Real-time polymerase chain reaction (PCR) analyses of a-SMA, TNF-a, Pit-1, Runx2, and osteocalcin in the grafts. Each gene
expression is shown as a ratio of that of the Preop-Y group (n ¼ 6 per group). *P<.05 by Tukey-Kramer honestly significant difference test. For abbre-
viations see Figures 1 and 2. CD, Cluster of differentiation; TNF-a, tumor necrosis factor-alpha; Pit-1, sodium–phosphate cotransporter; Preop-Y, young
group before transplantation; Y-ST, young syngeneic-transplant with standard diet; Y-LP, young syngeneic-transplant with low inorganic phosphate diet;
A-ST, adult syngeneic-transplant with standard diet; Preop-A, adult group before transplantation.
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FIGURE 4. Effects of TNF-a and Pi on SMCs. A, Immunocytochemistry of a-SMA, Runx2, and osteocalcin proteins in the cultured rat aortic SMCs
(RAOSMCs) and mouse osteoblast-like cells (mOBs; positive control). a-SMA antibody was conjugated with Cy3 (red). Runx2 and osteocalcin antibodies
as well as normal immunoglobulin (Ig, negative control) were labeled with Alexa488 (green). Nuclei were counterstained with 40,6-diamidino-2-
phenylindole (DAPI; blue). TNF-a(þ), 50 ng/mL of TNF-a in the media. Magnification 3400. Bar ¼ 50 mm. B and C, Real-time PCR analyses of
a-SMA, Runx2, osteocalcin, and Pit-1. Each gene expression is shown as a ratio of that without TNF-a (0 ng/mL) (n ¼ 4 per group). *,y,zP<.05 com-
pared with 0 ng/mL of TNF-a using the Dunnett test. D, Calcium deposition is highlighted in black by von Kossa staining. HP and LP, high phosphate
(4.5 mmol/L) and low phosphate (1.5 mmol/L) in the media. Magnification 3100. Bar ¼ 200 mm. E, Quantified calcium deposition in the RAOSMCs
cultured with 1.5 to 4.5 mmol/L of Pi. *P<.0001 by the Dunnett test (n ¼ 4 per group). F, RAOSMCs stimulated by TNF-a (50 ng/mL), HP, or both,
analyzed by electron microscopy. Asterisk indicates calcium deposition. G, Golgi apparatus. Magnifications: the TNF-a-HP group, 325,000; others,
320,000. Bar ¼ 1 mm. For abbreviations see Figures 1 to 3. TNF-a, Tumor necrosis factor-alpha; Pi, inorganic phosphate; SMC, smooth muscle
cell; a-SMA, a-smooth muscle actin; RAOSMC, rat aortic smooth muscle cell; PCR, polymerase chain reaction. Same as described in the abbreviation
box and in the legend of Figure 3.
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ence of lower iPTH levels in the young than in adults, pre-
sumably owing to the effects of growth hormone,14 is
inconsistent with the hyperparathyroidemia-related ectopic
calcification observed in uremia.7
Regarding the role of Pi on vascular calcification, in vitro
studies reported that high Pi enhanced the Pit-1 expression
together with Pi transport and triggered osteogenic transfor-
mation of SMCs.8,10 However, in the present study, why
were the grafts in young animals calcified only after528 The Journal of Thoracic and Cardiovascular Surgtransplantation? And why were osteogenic changes
observed in all posttransplant group grafts? Our response
to this is to suspect the effects of inflammation in
posttransplant grafts. TNF-a expression in posttransplant
grafts was enhanced together with the osteogenic markers
and Pit-1, irrespective of the animals’ ages or diets
(Figure 3, C-F). Similar findings are reported in a recent
study showing that the aortas of uremic patients, indepen-
dently of calcification status, enhanced coexpression of
TNF-a and bone morphogenetic protein-2,11 which isery c February 2013
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expression of the latter was enhanced similarly in the post-
transplant grafts in both age groups in our study (data not
shown). In vitro, TNF-a acts on vascular calcification
through the cyclic adenosine monophosphate/protein ki-
nase A (cAMP/PKA) pathway by enhancing DNA binding
of Runx2/Cbfa1 and activating downstream factors, for ex-
ample, osteocalcin and osteopontin.12 More recently, Pi
transport via Pit-1 was reported to be a necessary mediator
of mineralization downstream from the cAMP/PKA path-
way triggered by TNF-a, although Pit-1 expression was
not enhanced by the cAMP/PKA inducer.25 This is inconsis-
tent with our present finding of enhanced Pit-1 concurrent
with TNF-a expression in the posttransplant grafts and cul-
tured SMCs, which indicates involvement of a signaling
pathway other than cAMP/PKA. Then, our cultured
SMCs showing marked calcification only when both
TNF-a and high Pi were given were consistent with our
transplant model showing significant calcification only in
posttransplant grafts in young recipients. These observa-
tions suggest that a low Pi diet or Pi binders may prevent al-
lograft calcification in young patients. Considering the
limited growth rates observed in the rats fed a low-Pi diet,
however, local Pi inhibition or systemic Pi suppression to
the threshold level, which can reduce the graft calcification
without accompanying growth disturbance, may be
necessary.
Study Limitations
A subcutaneous transplant model using weanling rats has
conventionally been used to explore the mechanisms and
preventive methods of tissue calcification.17,22 The pattern
of graft media calcification seen in the allografts after
orthotopic implantation resembled that in the present
study.26 The suggested mechanisms of accelerating graft
calcification, however, require validation in circulatory im-
plant models, inasmuch as factors such as blood contact and
pulsatile pressure may affect allograft calcification differ-
ently. Despite the definite roles of Pi, the influences of other
relevant factors on allograft calcification and degeneration,
such as immunoreactions, apoptosis, and the function of py-
rophosphate, need further investigation. Also, this study has
not examined whether the growth retardation was related to
the suppression of musculoskeletal development or other
hormonal dysfunctions. Further investigation is necessary
to clarify the mechanism of this growth retardation and to
develop therapeutic strategies with weaker adverse effects.
CONCLUSIONS
In summary, this rat model suggests that growth-
associated hyperphosphatemia in young recipients, in con-
junction with osteogenic transformation of graft medial
SMCs, may be critical in promoting vascular allograft cal-
cification and is therefore potentially a therapeutic targetThe Journal of Thoracic and Cafor inhibiting allograft calcification and improving graft du-
rability in young recipients.
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